Presentations

A selection of presentations, originally presented at RDD Conferences or other scientific conferences, have been developed as electronic presentations.

RDD Online's Online Presentations are offered as interactive Powerpoint presentations synchronized with narration. Listeners can easily navigate the presentation using player buttons or slide thumbnails, or via a Search function. Presentations may be viewed on either a PC or Mac and require the Adobe Flash Player (version 10.1 or above) to be installed.
Get Adobe Flash Player

Highlights of the April 2018 Draft FDA Guidance on Quality Considerations for MDI and DPI Drug Products

Richard T. Lostritto, Ph.D., U.S. Food and Drug Administration, Silver Spring, Maryland, USA

Dr Lostritto presented the highlights of the April 2018 Draft FDA Guidance at Respiratory Drug Delivery 2018 in Tucson, Arizona.

New Tools for Generic OIDPs to Maximize Prospects of FDA Approval

Robert Lionberger, Ph.D., U.S. Food and Drug Administration, Silver Spring, Maryland, USA

Dr Lionberger reviewed new tools to maximize prospects of FDA approval for generic OINDPs at Respiratory Drug Delivery 2018 in Tucson, Arizona.

The Role of Comparative Analyses for Evaluation of Generic Drug-Device Combinations in an ANDA

Kimberley Witzmann, MD, U.S. Food and Drug Administration, Silver Spring, Maryland, USA

Dr Witzmann described the role of comparative analyses for evaluation of generic drug-device combinations at Respiratory Drug Delivery 2018 in Tucson, Arizona.

Harmonizing the Clinical Requirements for LABA/ICS Combinations in the USA and Europe

This 2 hour presentation was recorded at RDD Europe 2013 and will be of interest to scientists and regulatory affairs professionals.

This free presentation has been made possible by the generous support of RDD Online.

Economic and Environmental Initiatives for Inhaled Products

This 2 hour presentation was recorded at Respiratory Drug Delivery 2010 and will be of interest to scientists and regulatory affairs professionals.

This free presentation has been made possible by the generous support of 3M Drug Delivery Systems.

Role of Pharmacokinetics in Establishing Bioequivalence for Orally Inhaled Drug Products

This 3 hour presentation was recorded at Respiratory Drug Delivery 2010 and will be of interest to scientists and regulatory affairs professionals.

This free presentation has been made possible by the generous support of Product Quality Research Institute (PQRI).

Special Forum on Quality by Design (QbD): What Type of In Vitro - In Vivo Correlations are feasible?

Special Forum on Quality by Design (QbD): What Type of In Vitro - In Vivo Correlations are feasible?

This 75 minute presentation was recorded at Respiratory Drug Delivery 2008. It will be of interest to scientists and regulatory affairs professionals.

This free presentation has been made possible by the generous support of Respiratory Drug Delivery and Virginia Commonwealth University's Medical College of Virginia Foundation.

Can We Move Toward Harmonized Requirements for Bioequivalence of Inhalers?

Can We Move Toward Harmonized Requirements for Bioequivalence of Inhalers?

This 1 hour presentation was recorded at RDD Europe 2007 and will be of interest to scientists and regulatory affairs professionals.

This free presentation has been made possible by the generous support of Pfizer.

How Can We Improve Quality in Inhalation Drug Products?

How Can We Improve Quality in Inhalation Drug Products?

This 2 hour presentation was recorded at Respiratory Drug Delivery 2006.

This free presentation has been made possible by the generous support of Boehringer Ingelheim.

Condensation Aerosols

Pulmonary Delivery by Condensation Aerosols

This presentation was recorded at IX Deutsche Aerosol-Therapie-Seminar held in Nurnberg, Germany, November 2004.

This free presentation has been made possible by Chrysalis Technologies, now a division of Philip Morris, USA.

Selection & Validation of Impactors

Selection & Validation of Cascade Impactor Test Methods

This two hour presentation was recorded at Respiratory Drug Delivery IX and presents FDA and industry expert viewpoints on how to decide which cascade impactor is most appropriate for testing in support of NDA and ANDA US regulatory submissions concerning inhaled products.

This free presentation has been made possible by the generous support of Copley Scientific.

Introduction to Aerosols

Introduction to Inhaled Aerosols

This free, 15 minute presentation for scientists, managers and and business professionals presents a short introduction to the rapidly developing field of inhaled medication delivery.